Statutory Accounts





Director's Report


In accordance with the Corporations Act 2001, the directors of...

Related Keywords

United States , Canada , Australia , London , City Of , United Kingdom , City Of London , Thorney , Peterborough , Adelaide , South Australia , Australian , Spyridon Papapetropoulos , Kadrian Hinton , Ndas Blas , La Monte Carlo , David Wilson , Alan Fisher , Connor Bernstein , Merck Sharpe Dohme , Neurocrine Biosciences , Spyros Papapetropoulos , Alan Fisher Bcom , Dupont Merck , Jane Ryan , Nigel Stevenson , Liz Doolin , Cs Pharmaceuticals , Lundbeck , Rejuveron Life Sciences , Group Leadership Team , Neurocrine Biosciences Inc , Research Collaboration , Pfizer Inc , Group Treasury , Research Development , Therapeutic Inc , Allen Overy , Movement In Net Deferred Tax Liability , Remuneration Committee Of The Board , Development Incentive , Group As Lessor , Apeiron Investments Group Ltd , Subsidiaries Of Bionomics , Nasdaq , Bionomics Limited Is Ernst Young , Neurocrine Biosciences Bionomics Limited Ipos , Lipocine Inc , Development Incentives , Synaptic Pharmaceuticals , Group As Lessee , Teva Pharmaceuticals Inc , Carina Biotech Pty Ltd , Adamas Pharmaceuticals Inc , Risk Management Committee , Ernst Young , Rothschild Co , International Financial Reporting Standards , International Financial Reporting Board , Biogen Inc , Neuropore Therapies Inc , For Committee Member , Archemix Corp , Interactive Strength Inc , Apeiron Investment Group , Capital Markets Solutions , Australia Limited , Group Is Bionomics , Allergan , Drug Administration , Biodel Inc , Credit Suisse Group , Loan Movement Schedule , Risk Committee Meetings , Nikon Corporation , Bionomics Limited Or Company , Bionomics Limited , Risk Committee Of Thorney Technologies Limited , Bionomics Inc , Anatara Lifesciences Ltd , Ironwood Pharmaceuticals Inc , International Accounting Standards Board , Centrepoint Alliance Limited , Vigil Neuroscience Inc , Governance Institute Of Australia , Audit Services , Forward Foreign Exchange , National Institutes Of Health , Bionomics Limited The Company , Catalyst Biosciences Inc , Head Of Small Companies Corporate Broking , Bionomics Company , Iliad Chemicals Pty , Services Tax , Cavion Inc , Catalyst Bosciences Inc , Piper Jaffray Ltd , Ernst Young Global , Details Of The Group , Directors Of The Company , Wg Partners , Government Research , Therapeutics Inc , Directors Of Bionomics , Movements In Ordinary Shares Of The Company , Synaptic Pharmaceutical Corp , Queensland University , Remuneration Committee , Statutory Accounts , Corporations Act , Non Executive Director , Non Executive Chairman , Errol De Souza , Executive Chairman , Aaron Weaver , Miles Davies , Chief Executive Officer , Executive Director , Operating Results , Contingent Value Rights , Channel Expertise , Drive Growth , Pipeline Expansion , Continued Development , Depression Rating Scale , Insomnia Severity Index , Sheehan Disability Scale , Large Market , Significant Unmet Need , Ongoing Collaboration , Merck Sharpe , License Agreement , Legacy Oncology Assets , Carina Biotech , Expected Results , Options Granted , Employee Equity Plan , Share Option Plan , Risk Committee , Thorney Technologies Limited , Listed Directorships , Last Three Years , National Institutes , Cyclerion Therapeutics , Royalty Pharma , Catalyst Biosciences , Palatin Technologies , Previously Mr Wilson , Global Chairman , Group Leadership , Joint Head , United Kingdom Investment Banking Group , Deutsche Bank , Small Companies Corporate Finance , Small Companies Corporate , Senior Independent Director , Suisse Group , Chartered Financial Analyst , Interactive Strength , Managing Director , Enterprise Value , Chief Medical Officer , Chief Development Officer , Clinical Development , Acadia Pharmaceuticals Inc , Swanbio Therapeutics , Before Cavion , Teva Pharmaceuticals , Pharmaceuticals Inc , Chief Executive , Bionomics Company Secretary , Governance Institute , Corporate Secretariat , Corporate Governance , Company Secretary , Committee Member , William Street , Young Global , Professional Standards Legislation , Annual Report , Comprehensive Income , Income Tax , Comprehensive Loss , Consolidated Statement , Financial Position , Cash Flows , Operating Activities , Investing Activities , Financing Activities , Cash Equivalents , Financial Statements , Accounting Standards , Australian Accounting Standards Board , Australian Accounting Standards , Revised Accounting Standards , Income Taxe , Employee Benefits , Share Based Payment , Non Current Assets Held , Discontinued Operation , Contingent Liabilities , Contingent Asset , Long Term Employee , Bionomics Employee Equity Plan , Annual General Meeting , General Meeting , Consultancy Agreement , Employee Share Option Plan , Financial Assets , Effective Interest Method , Indefinite Lived Intangibles , Deferred Tax , Assets Acquired , Eclipse Therapeutic , Continuing Operations , Australian Government , Income Tax Recognised , Accounting Loss , Net Deferred Tax Liability Recognised , Net Deferred Tax Liability , Net Deferred Tax Asset Not Recognised , Tax Consolidation , Carrying Amounts , Ordinary Shares , Bionomics Employee Share Option Plan , Offer Date , Offer Date The , Monte Carlo , Currency Translation Reserve , Payments Reserve , Financial Instruments , Risk Management , Treasury Policy , Chief Financial Officer , Interest Rate Risk , Financial Reports , Operating Loss , Net Cash Outflow , Operating Assets , Per Share , Average Number , New Chief Executive Officer , Options Issued , Financial Statement , Equipment Commitments , Eclipse Therapeutics , Ironwood Pharmaceuticals , Corporations Regulations , Australian Auditing , Accounting Professional , Ethical Standards Board , Professional Accountants , Independence Standards , Australian Auditing Standards , Markets ,